Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Bown, Nick" or (type any "bookEditor journalEditor issueEditor" and editor="Bown, Nick")

Add to list
- Journal Article
- A1
- open access
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Angela Bellini, Ulrike Pötschger, Virginie Bernard, Eve Lapouble, Sylvain Baulande, Peter F. Ambros, Nathalie Auger, Klaus Beiske, Marie Bernkopf, David R. Betts, et al.

(2021) JOURNAL OF CLINICAL ONCOLOGY. 39(30). p.3377-3390
Add to list
- Conference Paper
- C3
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Robrecht Cannoodt (UGent) , Kimberly Verniers (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Nadine Van Roy (UGent) , Ana Pilar Berbegall, Julie Bienertova-Vasku, Nick Bown, et al.

(2016) OncoPoint, 4th Research seminar, Abstracts.
Add to list
- Journal Article
- A1
- open access
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Robrecht Cannoodt (UGent) , Kimberly Verniers (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Nadine Van Roy (UGent) , Ana Pilar Berbegall, Julie Bienertova-Vasku, Nick Bown, et al.

(2016) ONCOTARGET. 7(2). p.1960-1972
Add to list
- Conference Paper
- C3
Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Anneleen Decock (UGent) , Maté Ongenaert (UGent) , Robrecht Cannoodt (UGent) , Kimberly Verniers (UGent) , Bram De Wilde (UGent) , Genevieve Laureys (UGent) , Nadine Van Roy (UGent) , Ana Pilar Berbegall, Julie Bienertova-Vasku, Nick Bown, et al.

(2015) European Cancer Epigenetics conference, 1st, Abstracts.
Add to list
A multilocus technique for risk evaluation of patients with neuroblastoma

Inge M Ambros, Bettina Brunner, Gerhard Aigner, Clare Bedwell, Klaus Beiske, Jean Bénard, Nick Bown, Valerie Combaret, Jerome Couturier, Raffaella Defferrari, et al.

(2011) CLINICAL CANCER RESEARCH. 17(4). p.792-804

Academic Bibliography

Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

A multilocus technique for risk evaluation of patients with neuroblastoma

Contents

Support

Contact